Understanding how bacteria communicate with their human hosts
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
This study is looking at how bacteria protect themselves and how this might help us create better probiotics that can improve our gut health and support our immune system.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-11071838 on NIH RePORTER |
What this research studies
This research investigates the interactions between bacteria and their mammalian hosts, focusing on the bacterial immune system and its similarities to the human immune system. By studying how bacteria defend themselves against threats like bacteriophages, the research aims to uncover new pathways that could enhance the effectiveness of probiotic treatments. The methodology includes examining the prevalence and function of bacterial immune pathways within the human microbiome, which may lead to better-designed probiotics that can thrive in the gut and positively influence human immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in gut health, particularly those with gastrointestinal disorders or those seeking to improve their microbiome.
Not a fit: Patients who do not have any gastrointestinal issues or are not interested in probiotic treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved probiotic therapies that enhance gut health and immune function in humans.
How similar studies have performed: Previous research has shown promise in understanding bacterial communication and immune interactions, suggesting that this approach could yield valuable insights.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Whiteley, Aaron Thomas — University of Colorado
- Study coordinator: Whiteley, Aaron Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.